A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP

This study aimed to compare the efficacy and safety of rituximab (RTX) plus recombinant human thrombopoietin (rhTPO) with RTX alone in patients with immune thrombocytopenia (ITP) who had failed to respond to corticosteroids or relapsed. Recruited patients were randomized at a ratio of 2:1 into 2 gro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Zhou, Hai, Xu, Miao, Qin, Ping, Zhang, Hai-yan, Yuan, Cheng-lu, Zhao, Hong-guo, Cui, Zhong-guang, Meng, Yue-sheng, Wang, Lei, Zhou, Fang, Wang, Xin, Li, Da-qi, Bi, Ke-hong, Zhu, Chuan-sheng, Guo, Cheng-shan, Chu, Xiao-xia, Wu, Qing-chao, Liu, Xin-guang, Dong, Xiao-yuan, Li, Jie, Peng, Jun, Hou, Ming
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2015
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351949/
https://ncbi.nlm.nih.gov/pubmed/25575541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-581868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados